ER
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer (NCT02202746) | Clovis Oncology, Inc. | 2014-09-09 |
Track ER automatically
Every clearance here is in the API, with alerts when new ones post.